Abstract
High-dose rate brachytherapy for primary and secondary liver malignancies is an innovative radio-oncological modality enjoying rapid acceptance and adoption in the field of interventional oncology. It is a safe and effective treatment most useful in the salvage situation in patients with large hepatic tumors or an intermediate number of lesions unsuitable for thermal ablation or stereotactic external radiotherapy. In this chapter the radiobiological and technical aspects of CT-guided brachytherapy for the treatment of liver cancers are discussed. Clinical toxicity and efficacy outcomes after this technique are described including a comprehensive data review.
Keywords
- Planning Target Volume
- Colorectal Liver Metastasis
- Clinical Target Volume
- Stereotactic Body Radiation Therapy
- Local Tumor Control Rate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210
Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. doi:10.3322/caac.21262
El-Serag HB (2002) Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35(5 Suppl 2):S72–S78
Yang JD, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7(8):448–458. doi:10.1038/nrgastro.2010.100
Akoad ME, Pomfret EA (2015) Surgical resection and liver transplantation for hepatocellular carcinoma. Clin Liver Dis 19(2):381–399. doi:10.1016/j.cld.2015.01.007
Poultsides GA, Schulick RD, Pawlik TM (2010) Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome. HPB (Oxford) 12(1):43–49. doi:10.1111/j.1477-2574.2009.00121.x
Charalampoudis P, Mantas D, Sotiropoulos GC et al (2015) Surgery for liver metastases from breast cancer. Future Oncol 11(10):1519–1530. doi:10.2217/fon.15.43
Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191(1):38–46
Yu D, Chen W, Jiang C et al (2013) Risk assessment in patients undergoing liver resection. Hepatobiliary Pancreat Dis Int 12(5):473–479
Buscarini E, Savoia A, Brambilla G et al (2005) Radiofrequency thermal ablation of liver tumors. Eur Radiol 15(5):884–894. doi:10.1007/s00330-005-2652-x
Chen M, Li J, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243(3):321–328. doi:10.1097/01.sla.0000201480.65519.b8
Goldberg SN, Grassi CJ, Cardella JF et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20(7 Suppl):S377–S390. doi:10.1016/j.jvir.2009.04.011
Livraghi T, Solbiati L, Meloni F et al (2003) Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer 97(12):3027–3035. doi:10.1002/cncr.11426
Mack MG, Straub R, Eichler K et al (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data. Radiology 233(2):400–409. doi:10.1148/radiol.2332030454
Nikfarjam M, Muralidharan V, Christophi C (2006) Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery 139(1):73–81. doi:10.1016/j.surg.2005.07.030
Vogl TJ, Straub R, Eichler K et al (2004) Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data. Radiology 230(2):450–458. doi:10.1148/radiol.2302020646
Vogl TJ, Straub R, Zangos S et al (2004) MR-guided laser-induced thermotherapy (LITT) of liver tumours: experimental and clinical data. Int J Hyperthermia 20(7):713–724
Crocetti L, de Baere T, Lencioni R (2010) Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol 33(1):11–17. doi:10.1007/s00270-009-9736-y
Paulet E, Aubé C, Pessaux P et al (2008) Factors limiting complete tumor ablation by radiofrequency ablation. Cardiovasc Intervent Radiol 31(1):107–115. doi:10.1007/s00270-007-9208-1
Yin X, Xie X, Lu M et al (2009) Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer 115(9):1914–1923. doi:10.1002/cncr.24196
Pech M, Wieners G, Kryza R et al (2008) CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis. Strahlenther Onkol 184(6):302–306. doi:10.1007/s00066-008-1815-5
Ricke J, Wust P, Wieners G et al (2004) Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 15(11):1279–1286. doi:10.1097/01.RVI.0000141343.43441.06
Ricke J, Wust P, Stohlmann A et al (2004) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 58(5):1496–1505. doi:10.1016/j.ijrobp.2003.09.024
Curley SA (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15(1):11–13. doi:10.1245/s10434-007-9668-1
Stang A, Fischbach R, Teichmann W et al (2009) A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 45(10):1748–1756. doi:10.1016/j.ejca.2009.03.012
Collettini F, Schnapauff D, Poellinger A et al (2012) Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5–7 cm) and very large (7 cm) tumours. Eur Radiol 22(5):1101–1109. doi:10.1007/s00330-011-2352-7
Collettini F, Golenia M, Schnapauff D et al (2012) Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions. J Vasc Interv Radiol 23(5):618–626. doi:10.1016/j.jvir.2012.01.079
Collettini F, Singh A, Schnapauff D et al (2013) Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol 82(10):e509–e514. doi:10.1016/j.ejrad.2013.04.046
Geisel D, Denecke T, Collettini F et al (2012) Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (CT-HDRBT). Anticancer Res 32(12):5453–5458
Mohnike K, Wieners G, Schwartz F et al (2010) Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 78(1):172–179. doi:10.1016/j.ijrobp.2009.07.1700
Ricke J, Mohnike K, Pech M et al (2010) Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 78(2):479–485. doi:10.1016/j.ijrobp.2009.09.026
Schnapauff D, Denecke T, Grieser C et al (2011) Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol. doi:10.1007/s00270-011-0249-0
Schnapauff D, Collettini F, Hartwig K et al (2015) CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection. Anticancer Res 35(1):319–323
Tselis N, Chatzikonstantinou G, Kolotas C et al (2012) Hypofractionated accelerated computed tomography-guided interstitial high-dose-rate brachytherapy for liver malignancies. Brachytherapy. doi:10.1016/j.brachy.2012.02.006
Tselis N, Chatzikonstantinou G, Kolotas C et al (2013) Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study. Eur Radiol 23(8):2264–2270. doi:10.1007/s00330-013-2816-z
Wieners G, Mohnike K, Peters N et al (2011) Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy – a phase II-study. Radiother Oncol 100(2):314–319. doi:10.1016/j.radonc.2011.03.005
Ricke J, Thormann M, Ludewig M et al (2010) MR-guided liver tumor ablation employing open high-field 1.0T MRI for image-guided brachytherapy. Eur Radiol 20(8):1985–1993. doi:10.1007/s00330-010-1751-5
Wonneberger U, Fischbach F, Bunke J et al (2012) MRI-guided brachytherapy in the liver. In: Kahn T, Busse H (eds) Interventional magnetic resonance imaging. Springer, Berlin/Heidelberg, pp 381–387
Wybranski C, Eberhardt B, Fischbach K et al (2015) Accuracy of applicator tip reconstruction in MRI-guided interstitial (192)Ir-high-dose-rate brachytherapy of liver tumors. Radiother Oncol. doi:10.1016/j.radonc.2015.01.018
Tsalpatouros A, Baltas D, Kolotas C et al (1997) CT-based software for 3-D localization and reconstruction in stepping source brachytherapy. IEEE Trans Inf Technol Biomed 1(4):229–242
Purdy JA (2004) Current ICRU definitions of volumes: limitations and future directions. Semin Radiat Oncol 14(1):27–40. doi:10.1053/j.semradonc.2003.12.002
Lin Z, Lin J, Lin C et al (2012) 1.5T conventional MR-guided iodine-125 interstitial implants for hepatocellular carcinoma: feasibility and preliminary clinical experience. Eur J Radiol 81(7):1420–1425. doi:10.1016/j.ejrad.2011.03.043
Martinez-Monge R, Nag S, Nieroda CA et al (1999) Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer 85(6):1218–1225
Donath D, Nori D, Turnbull A et al (1990) Brachytherapy in the treatment of solitary colorectal metastases to the liver. J Surg Oncol 44(1):55–61
Thomas DS, Nauta RJ, Rodgers JE et al (1993) Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer 71(6):1977–1981
Wieners G, Pech M, Rudzinska M et al (2006) CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies. Eur Radiol 16(11):2586–2593. doi:10.1007/s00330-006-0241-2
Seidensticker M, Wust P, Rühl R et al (2010) Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol 5:24. doi:10.1186/1748-717X-5-24
Wybranski C, Seidensticker M, Mohnike K et al (2009) In vivo assessment of dose volume and dose gradient effects on the tolerance dose of small liver volumes after single-fraction high-dose-rate 192Ir irradiation. Radiat Res 172(5):598–606. doi:10.1667/RR1773.1
Streitparth F, Pech M, Böhmig M et al (2006) In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 65(5):1479–1486. doi:10.1016/j.ijrobp.2006.02.052
Dritschilo A, Harter KW, Thomas D et al (1988) Intraoperative radiation therapy of hepatic metastases: technical aspects and report of a pilot study. Int J Radiat Oncol Biol Phys 14(5):1007–1011
Franken NAP, Oei AL, Kok HP et al (2013) Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review). Int J Oncol 42(5):1501–1515. doi:10.3892/ijo.2013.1857
Park HC, Seong J, Han KH et al (2002) Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54(1):150–155
Guha C, Kavanagh BD (2011) Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol 21(4):256–263. doi:10.1016/j.semradonc.2011.05.003
Lawrence TS, Robertson JM, Anscher MS et al (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31(5):1237–1248. doi:10.1016/0360-3016(94)00418-K
Brenner DJ (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18(4):234–239. doi:10.1016/j.semradonc.2008.04.004
Milano MT, Constine LS, Okunieff P (2008) Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 3:36. doi:10.1186/1748-717X-3-36
Chang DT, Swaminath A, Kozak M et al (2011) Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117(17):4060–4069. doi:10.1002/cncr.25997
Dewas S, Mirabel X, Kramar A et al (2012) Radiothérapie stéréotaxique hépatique par CyberKnife(®): l’expérience lilloise (Stereotactic body radiation therapy for liver primary and metastases: the Lille experience). Cancer Radiother 16(1):58–69. doi:10.1016/j.canrad.2011.06.005
Rule W, Timmerman R, Tong L et al (2011) Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol 18(4):1081–1087. doi:10.1245/s10434-010-1405-5
Seo YS, Kim M, Yoo SY et al (2010) Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol 102(3):209–214. doi:10.1002/jso.21593
Timmerman RD, Kavanagh BD, Cho LC et al (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25(8):947–952. doi:10.1200/JCO.2006.09.7469
van der Pool AEM, Méndez Romero A, Wunderink W et al (2010) Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 97(3):377–382. doi:10.1002/bjs.6895
Kolotas C, Baltas D, Zamboglou N (1999) CT-Based interstitial HDR brachytherapy. Strahlenther Onkol 175(9):419–427
Kamrava M, Loh C, Banerjee R et al (2013) Dosimetric comparison of image-guided high-dose-rate interstitial liver brachytherapy vs liver stereotactic body radiation therapy. Brachytherapy 12:S18. doi:10.1016/j.brachy.2013.01.024
Li D, Kang J, Golas BJ et al (2014) Minimally invasive local therapies for liver cancer. Cancer Biol Med 11(4):217–236. doi:10.7497/j.issn.2095-3941.2014.04.001
Ricke J, Wust P (2011) Computed tomography-guided brachytherapy for liver cancer. Semin Radiat Oncol 21(4):287–293. doi:10.1016/j.semradonc.2011.05.005
Ruggieri R, Naccarato S, Nahum AE (2010) Severe hypofractionation: non-homogeneous tumour dose delivery can counteract tumour hypoxia. Acta Oncol 49(8):1304–1314. doi:10.3109/0284186X.2010.486796
Rühl R, Lüdemann L, Czarnecka A et al (2010) Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases. Radiat Oncol 5:44. doi:10.1186/1748-717X-5-44
Ricke J, Seidensticker M, Lüdemann L et al (2005) In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 62(3):776–784. doi:10.1016/j.ijrobp.2004.11.022
Lin Z, Chen J, Deng X (2012) Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation. Eur J Radiol 81(11):3079–3083. doi:10.1016/j.ejrad.2012.05.007
Nag S, DeHaan M, Scruggs G et al (2006) Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 64(3):736–744. doi:10.1016/j.ijrobp.2005.08.029
Collettini F, Poellinger A, Schnapauff D et al (2011) CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience. Anticancer Res 31(8):2597–2602
Collettini F, Lutter A, Schnapauff D et al (2014) Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT). Rofo 186(6):606–612. doi:10.1055/s-0033-1355887
Collettini F, Schreiber N, Schnapauff D et al (2015) CT-gesteuerte Hochdosis-Brachytherapie beim inoperablen hepatozellulären Karzinom (CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma). Strahlenther Onkol 191(5):405–412. doi:10.1007/s00066-014-0781-3
Denecke T, Stelter L, Schnapauff D et al (2015) CT-guided interstitial brachytherapy of hepatocellular carcinoma before liver transplantation: an equivalent alternative to transarterial chemoembolization? Eur Radiol. doi:10.1007/s00330-015-3660-0
Armstrong JG, Anderson LL, Harrison LB (1994) Treatment of liver metastases from colorectal cancer with radioactive implants. Cancer 73(7):1800–1804
Andolino DL, Johnson CS, Maluccio M et al (2011) Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81(4):e447–e453. doi:10.1016/j.ijrobp.2011.04.011
Katz AW, Carey-Sampson M, Muhs AG et al (2007) Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 67(3):793–798. doi:10.1016/j.ijrobp.2006.10.025
Kwon JH, Bae SH, Kim JY et al (2010) Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 10:475. doi:10.1186/1471-2407-10-475
Lee MT, Kim JJ, Dinniwell R et al (2009) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27(10):1585–1591. doi:10.1200/JCO.2008.20.0600
Rusthoven KE, Kavanagh BD, Cardenes H et al (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578. doi:10.1200/JCO.2008.19.6329
Tse RV, Hawkins M, Lockwood G et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26(4):657–664. doi:10.1200/JCO.2007.14.3529
Wulf J, Guckenberger M, Haedinger U et al (2006) Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45(7):838–847. doi:10.1080/02841860600904821
Goodman KA, Wiegner EA, Maturen KE et al (2010) Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78(2):486–493. doi:10.1016/j.ijrobp.2009.08.020
Herfarth KK, Debus J, Wannenmacher M (2004) Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial. Front Radiat Ther Oncol 38:100–105
Stintzing S, Hoffmann R, Heinemann V et al (2010) Radiosurgery of liver tumors: value of robotic radiosurgical device to treat liver tumors. Ann Surg Oncol 17(11):2877–2883. doi:10.1245/s10434-010-1187-9
Abbas H, Chang B, Chen ZJ (2014) Motion management in gastrointestinal cancers. J Gastrointest Oncol 5(3):223–235. doi:10.3978/j.issn.2078-6891.2014.028
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tselis, N., Mohnike, K., Ricke, J. (2016). Image-Guided High-Dose Rate Brachytherapy in the Treatment of Liver Cancer. In: Montemaggi, P., Trombetta, M., Brady, L. (eds) Brachytherapy. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/978-3-319-26791-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-26791-3_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26789-0
Online ISBN: 978-3-319-26791-3
eBook Packages: MedicineMedicine (R0)